These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9041180)

  • 1. A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17.
    Puget N; Torchard D; Serova-Sinilnikova OM; Lynch HT; Feunteun J; Lenoir GM; Mazoyer S
    Cancer Res; 1997 Mar; 57(5):828-31. PubMed ID: 9041180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a 3 kb Alu-mediated BRCA1 gene rearrangement in two breast/ovarian cancer families.
    Montagna M; Santacatterina M; Torri A; Menin C; Zullato D; Chieco-Bianchi L; D'Andrea E
    Oncogene; 1999 Jul; 18(28):4160-5. PubMed ID: 10435598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer family.
    Palanca Suela S; Esteban Cardeñosa E; Barragán González E; Oltra Soler S; de Juan Jiménez I; Chirivella González I; Segura Huerta A; Guillén Ponce C; Martínez de Dueñas E; Bolufer Gilabert P;
    Breast Cancer Res Treat; 2008 Nov; 112(1):63-7. PubMed ID: 18060491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients.
    Petrij-Bosch A; Peelen T; van Vliet M; van Eijk R; Olmer R; Drüsedau M; Hogervorst FB; Hageman S; Arts PJ; Ligtenberg MJ; Meijers-Heijboer H; Klijn JG; Vasen HF; Cornelisse CJ; van 't Veer LJ; Bakker E; van Ommen GJ; Devilee P
    Nat Genet; 1997 Nov; 17(3):341-5. PubMed ID: 9354803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid detection of novel BRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragments.
    Casilli F; Di Rocco ZC; Gad S; Tournier I; Stoppa-Lyonnet D; Frebourg T; Tosi M
    Hum Mutat; 2002 Sep; 20(3):218-26. PubMed ID: 12203994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel genomic rearrangements in the BRCA1 gene detected in Greek breast/ovarian cancer patients.
    Armaou S; Konstantopoulou I; Anagnostopoulos T; Razis E; Boukovinas I; Xenidis N; Fountzilas G; Yannoukakos D
    Eur J Cancer; 2007 Jan; 43(2):443-53. PubMed ID: 17174087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families.
    Hansen Tv; Jønson L; Albrechtsen A; Andersen MK; Ejlertsen B; Nielsen FC
    Breast Cancer Res Treat; 2009 May; 115(2):315-23. PubMed ID: 18546071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MLPA screening in the BRCA1 gene from 1,506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early-onset cases.
    Engert S; Wappenschmidt B; Betz B; Kast K; Kutsche M; Hellebrand H; Goecke TO; Kiechle M; Niederacher D; Schmutzler RK; Meindl A
    Hum Mutat; 2008 Jul; 29(7):948-58. PubMed ID: 18431737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions.
    Puget N; Stoppa-Lyonnet D; Sinilnikova OM; Pagès S; Lynch HT; Lenoir GM; Mazoyer S
    Cancer Res; 1999 Jan; 59(2):455-61. PubMed ID: 9927062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multi-exonic BRCA1 deletion identified in multiple families through single nucleotide polymorphism haplotype pair analysis and gene amplification with widely dispersed primer sets.
    Ward BD; Hendrickson BC; Judkins T; Deffenbaugh AM; Leclair B; Ward BE; Scholl T
    J Mol Diagn; 2005 Feb; 7(1):139-42. PubMed ID: 15681486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of a 161 kb deletion extending from the NBR1 to the BRCA1 genes in a French breast-ovarian cancer family.
    Gad S; Bièche I; Barrois M; Casilli F; Pages-Berhouet S; Dehainault C; Gauthier-Villars M; Bensimon A; Aurias A; Lidereau R; Bressac-de Paillerets B; Tosi M; Mazoyer S; Stoppa-Lyonnet D
    Hum Mutat; 2003 Jun; 21(6):654. PubMed ID: 14961556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. German family study on hereditary breast and/or ovarian cancer: germline mutation analysis of the BRCA1 gene.
    Hamann U; Brauch H; Garvin AM; Bastert G; Scott RJ
    Genes Chromosomes Cancer; 1997 Feb; 18(2):126-32. PubMed ID: 9115962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of the tumor suppressor BRCA1 locus in primates: implications for cancer predisposition.
    Pavlicek A; Noskov VN; Kouprina N; Barrett JC; Jurka J; Larionov V
    Hum Mol Genet; 2004 Nov; 13(22):2737-51. PubMed ID: 15385441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for large rearrangements of the BRCA1 gene in German breast or ovarian cancer families using semi-quantitative multiplex PCR method.
    Hofmann W; Görgens H; John A; Horn D; Hüttner C; Arnold N; Scherneck S; Schackert HK
    Hum Mutat; 2003 Jul; 22(1):103-4. PubMed ID: 12815601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for large rearrangements of the BRCA2 gene in Spanish families with breast/ovarian cancer.
    Gutiérrez-Enríquez S; de la Hoya M; Martínez-Bouzas C; Sanchez de Abajo A; Ramón y Cajal T; Llort G; Blanco I; Beristain E; Díaz-Rubio E; Alonso C; Tejada MI; Caldés T; Diez O
    Breast Cancer Res Treat; 2007 May; 103(1):103-7. PubMed ID: 17063271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease. Mutations in brief no. 224. Online.
    Claes K; Machackova E; De Vos M; Mortier G; De Paepe A; Messiaen L
    Hum Mutat; 1999; 13(3):256. PubMed ID: 10090482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gross rearrangements in BRCA1 but not BRCA2 play a notable role in predisposition to breast and ovarian cancer in high-risk families of German origin.
    Preisler-Adams S; Schönbuchner I; Fiebig B; Welling B; Dworniczak B; Weber BH
    Cancer Genet Cytogenet; 2006 Jul; 168(1):44-9. PubMed ID: 16772120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of five previously reported and recurrent BRCA1 genetic rearrangement mutations in 20,000 patients from hereditary breast/ovarian cancer families.
    Hendrickson BC; Judkins T; Ward BD; Eliason K; Deffenbaugh AE; Burbidge LA; Pyne K; Leclair B; Ward BE; Scholl T
    Genes Chromosomes Cancer; 2005 Jul; 43(3):309-13. PubMed ID: 15846789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations and alternative splicing of the BRCA1 gene in UK breast/ovarian cancer families.
    Xu CF; Chambers JA; Nicolai H; Brown MA; Hujeirat Y; Mohammed S; Hodgson S; Kelsell DP; Spurr NK; Bishop DT; Solomon E
    Genes Chromosomes Cancer; 1997 Feb; 18(2):102-10. PubMed ID: 9115959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.